Rapid Micro Biosystems (RPID) Interest Coverage Ratio (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Interest Coverage Ratio of 21.68 for Q1 2026, up 36.79% on a YoY basis from 15.85 in Q1 2025, and down 68.83% sequentially from 12.84 in Q4 2025.
Rapid Micro Biosystems (RPID) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Interest Coverage Ratio data on file, last reported at 21.68 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 36.79% year-over-year to 21.68; the trailing twelve-month figure through Mar 2026 stood at 21.28 (up 38.19% YoY), and the FY2025 full-year result was 0.5, up 16.58% from the prior year.
- Interest Coverage Ratio fell to 21.68 in Q1 2026, from 12.84 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1.02 in Q2 2025 to a low of 75.27 in Q2 2023.
- A 5-year average of 37.12 and a median of 34.3 in 2025 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio slumped 31172.02% in 2022 and jumped 98.47% in 2025, its largest moves.
- Tracing RPID's Interest Coverage Ratio over 5 years: stood at 30.77 in 2022, then fell by 20.41% to 37.05 in 2023, then surged by 56.45% to 16.13 in 2024, then rose by 20.42% to 12.84 in 2025, then slumped by 68.83% to 21.68 in 2026.
- Business Quant data shows RPID's Interest Coverage Ratio at 21.68 in Q1 2026, 12.84 in Q4 2025, and 28.43 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | -21.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.68 |
| Dec 31, 2025 | -12.84 |
| Sep 30, 2025 | -28.43 |
| Jun 30, 2025 | -1.02 |
| Mar 31, 2025 | -34.30 |
| Dec 31, 2024 | -16.13 |
| Sep 30, 2024 | -60.20 |
| Jun 30, 2024 | -66.89 |
| Mar 31, 2024 | -43.12 |
| Dec 31, 2023 | -37.05 |
| Sep 30, 2023 | -72.25 |
| Jun 30, 2023 | -75.27 |
| Mar 31, 2023 | -47.06 |
| Dec 31, 2022 | -30.77 |
| Sep 30, 2022 | -57.24 |
| Jun 30, 2022 | -1.56 |
| Mar 31, 2022 | -25.21 |
| Dec 31, 2021 | -20.82 |
| Sep 30, 2021 | -0.18 |
| Jun 30, 2021 | -0.23 |